Prospective observational registry for cystinuria patients on Thiola EC therapy

Brief description of study

The purpose of this research study is to follow patients on Thiola EC for two years and collect cystinuria related treatment information in order to see how they are doing. Thiola EC is Food and Drug Administration (FDA) approved for the treatment of cystinuria. This study is not testing Thiola EC.

Clinical Study Identifier: s20-00331 Identifier: NCT05048563
Principal Investigator: David S. Goldfarb.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.